Proteomic analysis was employed to investigate 8-nitrotryp’s anti-CRC mechanisms, specifically those targeting pathways (TGF-β/SMAD, PI3K/AKT/mTOR) known to be critical drivers in these subtypes. This evidence concerns the gene MTOR and colorectal carcinoma.